Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

Announcement type

All Financial Results 16741 Other Announcement 15911 Annual General Meeting 13141 Board Meeting Date 11186 Management Change 9423 Earnings Call 7037 Debt & Borrowing 5356 Board Meeting Outcome 4907 Annual Report 3231 Merger & Restructuring 2982 New Order Win 2904 Capital Structure Change 2685 Legal & Regulatory 2651 Business Update 2639 Results Update 2270 Employee Stock Options 2202 Fund Raise 2009 Dividend 1964 Price Movement Clarification 1707 Credit Rating 1476 Acquisition 1467 Capacity Expansion 1232 Promoter Buying 1127 Results Correction 833 Promoter Buying (Off-Market) 715 Share Pledge 643 Promoter Selling 570 Partnership 468 Adverse Business Impact 461 Product Launch 428 Production Started 401 Insolvency Petition 393 Regulatory Approval 353 Promoter Reclassification 345 Open Offer 325 Promoter Selling (Off-Market) 251 Bonus Issue 127 Order Update 92 ED Probe / Tax Survey 80 SME to Main Board Migration 56 IPO 34 Patent 23 Insurance Claim 11 Stock Split 5 Board Meeting Correction 2 Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

92 announcements with these filters

7 Apr 2026 14:34 IST BSE

Order Update Unimech Aerospace and Manufacturing Ltd UNIMECH

Unimech Aerospace and Manufacturing Order Update: ₹214 Cr

Unimech Aerospace reported a healthy Rs 214 Crore order book as of March 31, 2026. The company noted sequential improvement in demand conditions and order inflows during Q4-FY26, following recent U.S. tariff policy developments. Management expects year-on-year growth for the quarter, supported by a steady pipeline of new enquiries.

Value: ₹214.0 Cr

Read the filing ↗

4 Apr 2026 16:08 IST NSE

Order Update Fabtech Technologies Ltd FABTECH

Fabtech Technologies Order Update: ₹900 Cr

Fabtech Technologies Limited reported a robust consolidated order book exceeding ₹900 Crore as of March 31, 2026. Despite global logistics and cost challenges, the company secured high-impact projects in the pharmaceutical and animal health segments across Saudi Arabia and Africa, reinforcing its global growth trajectory.

Value: ₹900.0 Cr

Read the filing ↗